SIGA Technologies Inc (SIGA)
7.57
+0.21
(+2.85%)
USD |
NASDAQ |
Jun 28, 16:00
7.57
0.00 (0.00%)
After-Hours: 20:00
SIGA Technologies Cash from Financing (Quarterly): -0.159M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.159M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -35.87M |
| March 31, 2023 | -7.557M |
| December 31, 2022 | -2.853M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -36.52M |
| March 31, 2022 | -6.585M |
| December 31, 2021 | -5.757M |
| September 30, 2021 | -7.295M |
| June 30, 2021 | -6.600M |
| March 31, 2021 | -6.543M |
| December 31, 2020 | -6.720M |
| September 30, 2020 | -5.741M |
| June 30, 2020 | -15.22M |
| March 31, 2020 | -86.92M |
| December 31, 2019 | -0.9768M |
| September 30, 2019 | -0.1432M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0566M |
| December 31, 2018 | -2.357M |
| September 30, 2018 | -1.443M |
| June 30, 2018 | -0.0123M |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | -0.336M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.0565M |
| March 31, 2017 | -0.1931M |
| December 31, 2016 | 60.38M |
| September 30, 2016 | -1.294M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.0155M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.0122M |
| March 31, 2015 | -2.00M |
| December 31, 2014 | -0.50M |
| September 30, 2014 | -0.50M |
| June 30, 2014 | -0.4926M |
| March 31, 2014 | -0.8213M |
| December 31, 2013 | 0.7603M |
| September 30, 2013 | -7.244M |
| June 30, 2013 | 7.162M |
| March 31, 2013 | 1.035M |
| December 31, 2012 | 4.91M |
| September 30, 2012 | 0.0079M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.0017M |
| December 31, 2011 | -0.2473M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-86.92M
Minimum
Mar 2020
--
Maximum
Sep 2022
-12.18M
Average
-6.543M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| Calidi Biotherapeutics Inc | 3.013M |
| Mersana Therapeutics Inc | 5.829M |
| CNS Pharmaceuticals Inc | 3.459M |
| Disc Medicine Inc | 15.90M |
| Amylyx Pharmaceuticals Inc | 0.131M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.118M |
| Free Cash Flow | 64.23M |
| Free Cash Flow Per Share (Quarterly) | -0.0855 |
| Free Cash Flow to Equity (Quarterly) | -6.118M |
| Free Cash Flow to Firm (Quarterly) | -6.118M |
| Free Cash Flow Yield | 11.86% |